PII Redaction Agent

Automates the redaction of PII in documents, replacing sensitive data with synthetic placeholders to maintain privacy.

About the Agent

The PII Redaction Agent automates the redaction of Personally Identifiable Information (PII) in documents, replacing sensitive data with synthetic placeholders that preserve the document's structure and readability. Its sophisticated technology ensures precise detection and redaction of PII across multiple formats, upholding privacy laws and mitigating risks.

Challenges the PII Redaction Agent Addresses

As digital data containing personally identifiable information proliferates, data privacy issues have become more critical than ever. Manually redacting PII is not only labor-intensive but also prone to errors, increasing the likelihood of data breaches and compliance violations. With the imposition of stricter data privacy regulations, businesses urgently require an efficient and reliable solution that automates redaction without compromising document usability for testing, analysis, and operational purposes.

The PII Redaction Agent streamlines the process of securing sensitive information in documents. By automating the redaction and replacing PII with synthetic placeholders, the agent ensures that documents remain usable for further use while fully protecting user privacy. This automation helps organizations easily maintain data privacy and compliance, enhancing overall operational efficiency.

How the Agent Works

The PII Redaction Agent is designed to automate and optimize the redaction of Personally Identifiable Information (PII) from documents and communications. This agent is activated when it detects new content, such as uploaded documents or direct content shared with specific instructions, prompting it to initiate a sequence of well-defined, automated steps. Utilizing an advanced Large Language Model (LLM), the agent processes each document in real-time, identifying and redacting sensitive data. Below is a detailed breakdown of how the agent operates at each step of the process:


Step 1: Document Analysis and PII Identification

Upon users uploading new content, including emails and documents, the agent begins analyzing the content to identify any Personally Identifiable Information (PII). The agent first verifies the document format to ensure compatibility and proper configuration for processing. Utilizing a Large Language Model (LLM), it evaluates the structure, keywords, and context of the content to accurately detect PII.

Key Tasks:

  • Format Support Check: The agent verifies that the uploaded document format is supported and properly configured for processing.
  • Configure Triggers for Specific Conditions/Events: The agent can be configured to automatically trigger the PII redaction process based on predefined conditions or events, such as the detection of new content or fresh email arrivals.
  • Document Type Identification & Text Extraction: The agent classifies the document as a standard text file, selectable PDF, or scanned PDF. If necessary, Optical Character Recognition (OCR) is applied to convert scanned text into machine-readable content.
  • PII Detection and Classification: The agent uses the LLM to detect and categorize PII such as names, addresses, and contact numbers, ensuring all critical PII fields are extracted from both the main content and attachments.

Outcome:

  • PII Identification: The agent successfully detects and classifies all PII within the document, preparing it for redaction.

Step 2: PII Redaction and Placeholder Integration

The agent redacts identified PII from the document, replacing it with synthetic placeholders that maintain the document's original format and readability.

Key Tasks:

  • Automated Redaction: The agent securely removes all detected PII from the content.
  • Synthetic Placeholder Insertion: The agent replaces redacted text with synthetic placeholders that mimic the original data format, ensuring the document remains readable and coherent.
  • Formatting Adjustment: The agent ensures the redacted document remains professionally formatted and easy to interpret.

Outcome:

  • Anonymized Document: The content is securely redacted, with placeholders maintaining its structure and usability.

Step 3: Output Generation

The agent generates the final output, including a fully redacted document and a summary table that logs redacted information.

Key Tasks:

  • Final Document Compilation: The agent assembles the fully redacted document, integrating all redacted sections into a coherent final output.
  • Summary Table Creation: The agent generates a summary table documenting each redacted instance, specifying the original PII, the synthetic placeholder, and the PII category.
  • Output Delivery: The agent securely delivers the redacted document and summary table to the designated storage or recipient.

Outcome:

  • Redacted Document and Summary Table Delivery: A compliance-ready document is provided, ensuring full data security and traceability.

Step 4: Human Feedback Integration

The agent collects feedback from users to assess the effectiveness of the redaction process and refine its accuracy.

Key Tasks:

  • Feedback Collection: Users review the redacted content, providing feedback on accuracy, readability, and compliance adherence.
  • Performance Analysis: The agent analyzes feedback to detect patterns or recurring issues, guiding improvements in redaction algorithms.
  • Algorithm Adjustment: The agent updates its operations based on feedback to improve future redactions and adapt to evolving data protection needs.

Outcome:

  • Continuous Improvement: The agent evolves through iterative learning, maintaining high precision and efficiency in handling PII redaction.

Why Use the PII Redaction Agent?

  • Enhanced Privacy and Compliance: The PII Redaction Agent automates sensitive data masking, ensuring compliance with data protection laws.
  • Time and Cost Efficiency: Automated redaction reduces manual labor, accelerating document processing and lowering operational costs.
  • Flexibility and Customization: The agent adapts to industry-specific privacy standards, making it applicable across different sectors.
  • Compatibility: The agent supports various file types, including scanned PDFs, offering flexibility for diverse document formats.
  • Traceability and Transparency: The generated summary table provides clear documentation of redacted data, facilitating audits and compliance checks.

Download the solution document

Accuracy
TBD

Speed
TBD

Input Data Set

Sample of data set required for PII Redaction Agent:

Comprehensive Medical Report

Patient Information

  • Name: Katherine Johnson
  • Date of Birth: 1988-11-23
  • Gender: Female
  • Address: 452 Maple Lane, Denver, CO, 80211
  • Phone: (720) 555-4891
  • Email: k.johnson88@gmail.com
  • Patient ID: 83729145
  • Insurance Provider: Blue Cross Blue Shield
  • Policy Number: BCBS-00398457
  • Emergency Contact: Michael Johnson (Brother) - (303) 555-9381

Appointment Details

  • Visit Date: 2024-02-10
  • Physician: Dr. Jonathan Miller, MD
  • Department: Endocrinology
  • Clinic Location: University Hospital, Suite 402
  • Referral Source: Dr. Emily Carter (Primary Care Physician)
  • Reason for Visit: Follow-up on Type 2 Diabetes management and assessment of new symptoms, including fatigue and dizziness.

Medical History

  • Chronic Conditions:
    • Type 2 Diabetes Mellitus (diagnosed in 2015)
    • Hypertension (diagnosed in 2018)
    • Hypercholesterolemia (diagnosed in 2019)
    • Seasonal Allergies (diagnosed in 2005)
  • Past Surgeries:
    • Appendectomy (2002)
    • Cholecystectomy (2011)
    • Tonsillectomy (1995)
  • Family History:
    • Father: Type 2 Diabetes, Hypertension
    • Mother: Hypercholesterolemia, Osteoporosis
    • Sibling: None
  • Lifestyle Factors:
    • Smoker: Never
    • Alcohol Consumption: Rarely (1–2 drinks per month)
    • Physical Activity: Moderate (30 minutes walking daily)
    • Dietary Habits: High-carbohydrate diet; low vegetable intake

Current Medications

  • Prescribed:
    • Metformin 750mg twice daily
    • Lisinopril 10mg daily
    • Atorvastatin 20mg nightly
  • Over-the-Counter (OTC):
    • Vitamin D3 2000 IU daily
    • Aspirin 81mg daily (for cardiovascular protection)
  • Supplements:
    • Fish Oil 1000mg daily

Allergies

  • Drug Allergies: None reported
  • Food Allergies: None reported
  • Environmental Allergies: Dust mites, seasonal pollen

Clinical Observations

  • Vital Signs:
    • Blood Pressure: 150/95 mmHg (elevated)
    • Heart Rate: 82 bpm
    • Respiratory Rate: 16 breaths/minute
    • Weight: 78 kg (BMI: 27.5, overweight)
    • Height: 1.68 m (5’6”)
  • Physical Exam Findings:
    • Skin: No rashes or lesions; slight dryness observed on forearms
    • Eyes: Mild conjunctival pallor; no jaundice
    • Cardiovascular: Regular rate and rhythm, no murmurs or gallops
    • Lungs: Clear to auscultation bilaterally
    • Abdomen: Soft, non-tender; no hepatosplenomegaly
    • Extremities: No edema; pulses palpable and symmetric

Laboratory Results

Blood Tests

Test Result Reference Range
Fasting Glucose 240 mg/dL 70–99 mg/dL
HbA1c 8.7% <5.7%
Total Cholesterol 210 mg/dL <200 mg/dL
LDL Cholesterol 160 mg/dL <100 mg/dL
HDL Cholesterol 40 mg/dL >50 mg/dL (female)
Triglycerides 220 mg/dL <150 mg/dL
Hemoglobin 11.5 g/dL 12.0–15.5 g/dL
Creatinine 1.1 mg/dL 0.6–1.2 mg/dL
GFR 78 mL/min >90 mL/min
ALT (Liver Enzyme) 25 U/L 7–35 U/L

Imaging

  • Chest X-Ray: Normal findings
  • Abdominal Ultrasound: No abnormalities detected

Diagnosis

  • Primary Diagnosis: Poorly controlled Type 2 Diabetes Mellitus with evidence of hyperlipidemia and early nephropathy.
  • Secondary Concerns:
    • Suspected anemia (fatigue, pallor, low hemoglobin levels).
    • Persistent hyperlipidemia despite current statin therapy.

Treatment Plan

1. Medications

  • Increase Metformin dosage from 750mg to 1000mg twice daily.
  • Add Empagliflozin 10mg daily for improved glucose control and kidney protection.
  • Switch from Atorvastatin to Rosuvastatin 10mg daily for improved LDL reduction.
  • Prescribe Iron supplements (Ferrous Sulfate 325mg daily) to address suspected anemia.

2. Lifestyle Modifications

  • Transition to a low-glycemic, Mediterranean-style diet.
  • Increase physical activity to 45 minutes of moderate aerobic exercise, 5 days per week.
  • Enroll in a diabetes education program for improved dietary adherence.

3. Follow-Up Tests

  • Full blood count (to confirm anemia diagnosis).
  • Urine microalbumin test (to monitor kidney function).
  • Lipid profile recheck in 3 months.

4. Next Appointment

  • Scheduled for 2024-03-15.

Physician Notes

The patient was counseled on the importance of medication adherence and lifestyle changes to prevent further complications from diabetes. Recommended joining a support group for lifestyle coaching. Reassured the patient that current symptoms are manageable with the proposed plan.


Deliverable Example

Sample output delivered by the PII Redaction Agent:

Comprehensive Medical Report

Patient Information

  • Name: [NAME]
  • Date of Birth: [DOB]
  • Gender: [GENDER]
  • Address: [ADDRESS]
  • Phone: [PHONE]
  • Email: [EMAIL]
  • Patient ID: [PATIENT_ID]
  • Insurance Provider: [INSURANCE_PROVIDER]
  • Policy Number: [POLICY_NUMBER]
  • Emergency Contact: [EMERGENCY_CONTACT_NAME] ([EMERGENCY_CONTACT_RELATIONSHIP]) - [EMERGENCY_CONTACT_PHONE]

Appointment Details

  • Visit Date: 2024-02-10
  • Physician: [PHYSICIAN_NAME]
  • Department: Endocrinology
  • Clinic Location: [CLINIC_LOCATION]
  • Referral Source: [REFERRAL_SOURCE]
  • Reason for Visit: Follow-up on Type 2 Diabetes management and assessment of new symptoms, including fatigue and dizziness.

Medical History

  • Chronic Conditions:
    • Type 2 Diabetes Mellitus (diagnosed in 2015)
    • Hypertension (diagnosed in 2018)
    • Hypercholesterolemia (diagnosed in 2019)
    • Seasonal Allergies (diagnosed in 2005)
  • Past Surgeries:
    • Appendectomy (2002)
    • Cholecystectomy (2011)
    • Tonsillectomy (1995)
  • Family History:
    • Father: [FATHER-HISTORY]
    • Mother: [MOTHER-HISTORY]
    • Sibling: [SIBLING-HISTORY]
  • Lifestyle Factors:
    • Smoker: Never
    • Alcohol Consumption: Rarely (1–2 drinks per month)
    • Physical Activity: Moderate (30 minutes walking daily)
    • Dietary Habits: High-carbohydrate diet; low vegetable intake

Current Medications

  • Prescribed:
    • Metformin 750mg twice daily
    • Lisinopril 10mg daily
    • Atorvastatin 20mg nightly
  • Over-the-Counter (OTC):
    • Vitamin D3 2000 IU daily
    • Aspirin 81mg daily (for cardiovascular protection)
  • Supplements:
    • Fish Oil 1000mg daily

Allergies

  • Drug Allergies: None reported
  • Food Allergies: None reported
  • Environmental Allergies: Dust mites, seasonal pollen

Clinical Observations

  • Vital Signs:
    • Blood Pressure: 150/95 mmHg (elevated)
    • Heart Rate: 82 bpm
    • Respiratory Rate: 16 breaths/minute
    • Weight: 78 kg (BMI: 27.5, overweight)
    • Height: 1.68 m (5’6”)
  • Physical Exam Findings:
    • Skin: No rashes or lesions; slight dryness observed on forearms
    • Eyes: Mild conjunctival pallor; no jaundice
    • Cardiovascular: Regular rate and rhythm, no murmurs or gallops
    • Lungs: Clear to auscultation bilaterally
    • Abdomen: Soft, non-tender; no hepatosplenomegaly
    • Extremities: No edema; pulses palpable and symmetric

Laboratory Results

Blood Tests

Test Result Reference Range
Fasting Glucose 240 mg/dL 70–99 mg/dL
HbA1c 8.7% <5.7%
Total Cholesterol 210 mg/dL <200 mg/dL
LDL Cholesterol 160 mg/dL <100 mg/dL
HDL Cholesterol 40 mg/dL >50 mg/dL (female)
Triglycerides 220 mg/dL <150 mg/dL
Hemoglobin 11.5 g/dL 12.0–15.5 g/dL
Creatinine 1.1 mg/dL 0.6–1.2 mg/dL
GFR 78 mL/min >90 mL/min
ALT (Liver Enzyme) 25 U/L 7–35 U/L

Imaging

  • Chest X-Ray: Normal findings
  • Abdominal Ultrasound: No abnormalities detected

Diagnosis

  • Primary Diagnosis: Poorly controlled Type 2 Diabetes Mellitus with evidence of hyperlipidemia and early nephropathy.
  • Secondary Concerns:
    • Suspected anemia (fatigue, pallor, low hemoglobin levels).
    • Persistent hyperlipidemia despite current statin therapy.

Treatment Plan

1. Medications

  • Increase Metformin dosage from 750mg to 1000mg twice daily.
  • Add Empagliflozin 10mg daily for improved glucose control and kidney protection.
  • Switch from Atorvastatin to Rosuvastatin 10mg daily for improved LDL reduction.
  • Prescribe Iron supplements (Ferrous Sulfate 325mg daily) to address suspected anemia.

2. Lifestyle Modifications

  • Transition to a low-glycemic, Mediterranean-style diet.
  • Increase physical activity to 45 minutes of moderate aerobic exercise, 5 days per week.
  • Enroll in a diabetes education program for improved dietary adherence.

3. Follow-Up Tests

  • Full blood count (to confirm anemia diagnosis).
  • Urine microalbumin test (to monitor kidney function).
  • Lipid profile recheck in 3 months.

4. Next Appointment

  • Scheduled for 2024-03-15.

Physician Notes

The patient was counseled on the importance of medication adherence and lifestyle changes to prevent further complications from diabetes. Recommended joining a support group for lifestyle coaching. Reassured the patient that current symptoms are manageable with the proposed plan.


Related Agents